Eculizumab Biosimilar - Research Grade,ichor.bio,ICH4005
Detects human Complement protein C5. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Eculizumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB448095369
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameEculizumab Biosimilar - Research Grade
Cat. No.ICH4005
Accession NumberP01031
HostHumanized
IsotypeIgG2/4 kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetComplement protein C5
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Eculizumab biosimilar is a recombinant humanized monoclonal IgG2/4_ antibody produced by Chinese hamster ovary cell culture and purified by standard bioprocess technology. Eculizumab biosimilar contains human constant regions from human IgG2 sequences and
Synonyms
C5
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.